Literature DB >> 2293700

Promontory stimulation following labyrinthectomy: implications for cochlear implantation.

J M Kartush1, C J Linstrom, M D Graham, K C Kulick, K R Bouchard.   

Abstract

Transtympanic electric promontory stimulation is a psychoacoustic test used to assess residual acoustic neurons in profound sensorineural hearing loss. The test was performed in six patients who had previously undergone transmastoid (N = 5) or transcanal-oval window (N = 1) labyrinthectomy as a means of determining the feasibility of future cochlear implantation. Four patients had unilateral Meniere's disease, one had labyrinthitis, and one had delayed onset vertigo. All patients perceived a definite auditory sensation in the labyrinthectomized ear during stimulation. The results of threshold, dynamic range, and difference limen testing were similar to those obtained during preoperative stimulation of cochlear implant candidates (N = 12) who subsequently became successful users. There was no evidence of response degradations as the time following labyrinthectomy increased. The results of this study suggest the possibility of successful cochlear implantation following labyrinthectomy. Supporting histologic data are reviewed.

Entities:  

Mesh:

Year:  1990        PMID: 2293700     DOI: 10.1288/00005537-199001000-00002

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  3 in total

1.  Autoimmune or immune-mediated causes of deafness.

Authors:  J P Harris
Journal:  West J Med       Date:  1991-06

2.  CNAP To Predict Functional Cochlear Nerve Preservation in NF-2: Cochlear Implant or Auditory Brainstem Implant.

Authors:  Enrico Piccirillo; Maurizio Guida; Sean Flanagan; Lorenzo Lauda; Paolo Fois; Mario Sanna
Journal:  Skull Base       Date:  2008-07

3.  Simultaneous Translabyrinthine Tumor Removal and Cochlear Implantation in Vestibular Schwannoma Patients.

Authors:  Jin Won Kim; Ji Hyuk Han; Jin Woong Kim; In Seok Moon
Journal:  Yonsei Med J       Date:  2016-11       Impact factor: 2.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.